Sessions/Tracks
Pharmaceutical Conferences 2019 describes drug design is the method of inventing
innovative medications. Drug design and Drug formulation defines the design of molecules that are corresponding in shape and charge to the bio molecular target with which they interact and therefore will bind to it. Generally, the drug is a tiny
organic molecule which triggers or slows down the activity of a
bio-molecule such as a protein which repeatedly results in a medicinal benefit to the patient. Discovery of drugs and Drug formulation is challenging. Various
medications are invented by chance observations, the scientific examination of other medicines or by finding out the side effects of some other drugs. A
methodical technique is significant screening observations where important
drug targets are tested with thousands of various compounds to observe, whether conversations occur. Basically,
Drug Formulationand drug design involves
drug design of small molecules that are harmonizing in shape and charge to the
bio molecular target to which they act together and consequently will bind to it.
Related Pharma Societies | Pharma Associations
Drug Formulation Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT).
By using computational methods and the
3D structural information of the
protein target, we are now able to scrutinize the detailed underlying molecular and atomic interactions involved in ligand: protein interactions and thus interpret experimental results in detail. The use of computers in drug formulation and
drug discovery bears the additional advantage of delivering new drug candidates more rapidly and cost-efficiently.
Computer-aided drug discovery has recently had important successes in drug formulation: new ligands have been predicted along with their
receptor-bound structures and in several circumstances the achieved hit rates (ligands discovered per molecules tested) have been significantly greater than through experimental high-throughout screening. Strategies for CADD vary depending on the extent of structural and other information available regarding the target (enzyme/receptor) and the
ligands.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association ( PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Drug Formulation Congress 2019,
Pharmaceutical Conferences 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), Pharmaceutical Drug Formulation,
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Technological advancements in the molecular characterization of cancers have assisted researchers to identify an increasing number of
key molecular drivers of cancer progression. These drug discoveries have led to multiple novel
anticancer therapeutics, and clinical advantage in selected
patient populations. Despite this, the identification of clinically relevant predictive biomarkers of response continues to lag behind. In this review, we discuss strategies for the molecular characterization of cancers and the importance of biomarkers for the development of
novel antitumor therapeutics.
The discovery and evaluation of any novel biomarkers will ideally be specialized to Clinical Laboratory Improvement Amendments (CLIA) and
Good Clinical Laboratory Practice (GCLP) standards, so as to ensure accuracy and reproducibility of laboratory procedures. Predictive biomarkers indicate the likelihood of response to a specific antitumor therapy. Such assays should be scientifically sound, Predictive biomarkers include both tumor-specific and surrogate biomarkers and are crucial to accelerating the
drug development process.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Drug Formulation is the study of relationships between pre-formulation, pharmaceutical formulation, delivery, disposition and clinical response. The
inherent instability nature of a new drug will alter its preferred form into undesired form when presented in a suitable dosage form with the
excipient/s upon storage. In early days this process was restricted only for assessing few characteristics, but today this process is being considered as a formulation strategy and hence
tremendous technological advancement has been accomplished in this field which enables us to save time and money through planned management system and hence impacts Drug Formulation 2017 to be a
Drug Formulation Conference. Use of glorious statistical software even based on artificial neural networking are made the task of pre-formulation and optimization process easier. Role of pre formulation studies techniques like
freeze drying aspects projects the event Drug Formulation 2017 to pose as a freeze drying meeting in drug discovery, drug development plays major role in
pharmaceutical drug formulation development and the revisions will help in different dosage forms design. With the increasing number of novel and specialized compounds being developed, a "one size fits all" approach to drug formulation and delivery is no longer optimal, necessitating the consideration of drug formulations unique to each drug.
NDDS conference will discuss on
Premature Approaches, Present Scenario and Future Prospects of Pre-formulation events. There are more than 1400 sustained or
controlled release drugs have been approved all over the world.
Pharmaceutical conferences discuss the state-of-art technology being applied and involve advances in drug formulation studies.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, Pharmaceutical Drug Formulation, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Pharmacokinetics is currently defined as the study of the time course of drug absorption, distribution, metabolism, and excretion. Clinical pharmacokinetics is the application of pharmacokinetic principles to the safe and effective
therapeutic management of drugs in an individual patient. Primary goals of clinical pharmacokinetics and drug formulation include enhancing efficacy and decreasing toxicity of a patient’s drug therapy. The development of strong correlations between drug concentrations and their
pharmacologic responses has enabled clinicians to apply pharmacokinetic principles to actual patient situations.
Pharmacodynamics refers to the relationship between drug concentration at the site of action and the resulting effect, including the time course and intensity of therapeutic and
adverse effects. The effect of a drug present at the site of achievement is determined by that drug’s binding with a receptor. Receptors may be present on neurons in the
central nervous system (i.e., opiate receptors) to depress pain sensation, on cardiac muscle to affect the intensity of contraction, or even within bacteria to disrupt maintenance of the bacterial cell wall
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Drug Formulation, Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Clinical Biotherapeutic aspects including study drug formulations, drug design, drug-drug interactions, QT assessment, immunogenicity, comparability, special populations (hepatic and liver failure), PK and PD, regulatory expectations of PK and PD characterization, as well as reviewing factors which influence the ADME of Biotherapeutics. The objectives of early clinical development of
therapeutic proteins are the same as for small molecules i.e. to investigate the molecule in a manner that will gain necessary knowledge about its tolerability safety pharmacokinetics (PK) and if possible pharmacodynamics (PD) effects in the most appropriate human populations while simultaneously protecting their safety. However, there are specific features of proteins that must be considered when designing
clinical pharmacology studies.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Drug Formulation, Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Size reduction is a fundamental unit operation having important applications in Pharmaceutical Sciences ,Drug Formulations. It helps in improving solubility and
bioavailability, reducing toxicity, enhancing release and providing better drug formulation opportunities for drugs. In most of the cases, size reduction is limited to micron size range, for example, various pharmaceutical dosage forms like powder, emulsion, suspension etc. Drugs in the nano meter size range enhance performance in a variety of dosage forms. Major advantages of nanosizing include (i) increased surface area, (ii) enhanced solubility, (iii) increased rate of dissolution, (iv) increased oral bioavailability, (v) more rapid onset of therapeutic action, (vi) less amount of dose required, (vii) decreased fed/fasted variability, and (viii) decreased
patient-to-patient variability.
Pharmaceutical nanotechnology has provided more fine-tuned diagnosis and focused treatment of disease at a molecular level
. Pharmaceutical nanotechnology is most innovative and highly specialized field, which will revolutionize the pharmaceutical industry in near future. Pharmaceutical nanotechnology presents revolutionary opportunities to fight against many diseases. It helps in detecting the antigen associated with diseases such as cancer,
diabetes mellitus, neurodegenerative diseases, as well as detecting the microorganisms and viruses associated with infections. It is expected that in next 10 years market will be flooded with
nanotechnology devised medicine.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Drug Formulation, Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Identifying
drug targets plays essential roles in designing new drugs, drug formulations and
combating diseases. Unfortunately, our current understanding about drug targets is far from comprehensive. Screening drug targets in the lab is an expensive and
time-consuming procedure. In the past decade, the accumulation of various types of study of science related data makes it possible to develop
computational approaches to predict drug targets.
Non-communicable diseases such as cancer, atherosclerosis and diabetes are responsible for most important social and health affliction as millions of people are dying every year. Out of which,
atherosclerosis is the leading cause of deaths worldwide. The
lipid abnormality is one of the most important modifiable risk factors for atherosclerosis. Both genetic and environmental components are associated with the development of atherosclerotic plaques. Immune and
inflammatory mediators have a complex role in the initiation and progression of atherosclerosis. Understanding of all these processes will help to invent a range of new
biomarkers and novel treatment modalities targeting various cellular events in acute and chronic inflammation that are accountable for atherosclerosis. Several
biochemical pathways, receptors and enzymes are involved in the development of atherosclerosis that would be possible targets for improving strategies for
disease diagnosis and management.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry,
Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Drug Formulation, Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT).
Medicinal Chemistry is a branch of chemistry which especially agreements with synthetic organic chemistry and
pharmacology including various other
biological specialties which is involved with design. It combines knowledge and capacities from the fields of
cheminformatics, molecu, chemical creation and development of drug for marketing of pharmaceutical agents lar modeling and important
bioinformatics and drug formulations, demands an in-depth appreciative of the
physico-chemical properties of a three-dimensional molecule. The information base required by today's medicinal chemist has increased dramatically and has highlighted an rising challenge for chemists to understand the growing field of
drug design.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of New Zealand (PSNZ), Pharmaceutical Association of Mauritius(PAM), Pharmaceutical Drug Formulation,
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Related Pharma Societies | Pharma Associations
Society for Clinical Trials,
Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Drug Formulation, Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Pharmaceutical engineering is a branch of
pharmaceutical science and technology that involves development and manufacturing of products, processes, and components in the
pharmaceuticals industry (i.e. drugs & biologics). While developing pharmaceutical products involves many interrelated disciplines (e.g. medicinal chemists, analytical chemists, clinicians/pharmacologists, pharmacists, chemical engineers,
biomedical engineers, etc.), the specific subfield of "pharmaceutical engineering" has only emerged recently as a
divergent engineering discipline. This now brings the problem-solving principles and quantitative training of engineering to complement the other
scientific fields already involved in
drug formulations
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT).
Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times
post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the Regulatory Affairs’ department. Regulatory Affairs professionals can play a key role in guiding drug formulations strategy in an increasingly
global environment. But they also play an important
operational role, for example, by considering the best processes to follow and enabling structured interaction with regulatory authorities. Regulatory Affairs is driven by good science and accordingly nothing
remains static.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
Bioequivalence studies are done for both Early & late
Clinical Trial formulations, Drug formulations used in clinical trials and stability studies, if different Clinical trial formulations and to-be-marketed drug product when it comes to cost and productivity metrics, it’s often said that what gets measured gets done. Bioequivalence is determined based on the bioavailability of the innovator medicine versus the
generic medicine. The outline for bioequivalence study includes the organization of test and reference items on two events to volunteer subjects, with every organization isolated by a washout period. This Study involves parameters on (Cmax) and (AUC),
Statistical evaluation.
Assessment of the
bioequivalence of generic versions of certain reference drugs is complicated by the presence of endogenous levels of said compounds which cannot be distinguished from externally derived compound levels following drug administration. If unaccounted for, the presence of endogenous compound biases towards
equivalence in bioequivalence studies of these drugs. Bioequivalence assessments may be complicated further as disposition of the exogenous analogue can be subject to various endogenous processes resulting in nonlinear
pharmacokinetics. To overcome these inherent biases a number of different strategies have been employed.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
The aim of
bioavailability study is to find out the
dosage form influence on the biological performance of the drug, sensitivity to detect differences in the rate and extent of absorption. Bioavailability and
bioequivalence study design involves Single dose or multi dose standard 2x 2 crossovers, Parallel groups, for more than two drug formulations. Study drug design meant for estimating essential
pharmacokinetic parameters differs significantly from a bioequivalence study meant for comparing the
test formulation. The results of a pilot study can be used as the sole basis to document BA or BE provided the study’s design and execution are suitable and enough subjects have completed the study
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
The global market for Business Development of
Drug Delivery Technology in 2010 was $131.6 billion and is expected to rise at a compound annual growth rate (CAGR) of 5% and reach nearly $175.6 billion by 2016. The U.S constituted approximately 59% of the total drug delivery market in 2010 and was $78 billion. It is forecast to reach nearly $103 billion in 2016 at a CAGR of 4.7%. Europe contributed about 27% of the total
drug delivery market in 2010 and was $36 billion and is expected to grow to $49 billion by 2016 at a CAGR of 5.6% in 2013, Drug Delivery Global market reached $150.3 billion, according to BCC research. This was an increase from $142 billion the previous year. Given its predicted annual growth the market represents a considerable business opportunity, which has been reflected in increasing number of drug delivery specialists. Consistent quality and competitive costs of product improves Production performance and continuity of supply and Product and technology auditing and due diligence with minimizing Regulatory Issues, drug formulation, quality control, and business development Business opportunities in drug delivery.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
In
bioscience and drugs, to small grade molecule may be a coffee mass (<900 Daltons [1]) compound which is incapable to facilitate regulate a process, with a size on the order of 10−9 m. Most drug analysis square measure identical little molecules. For analysis of small organic molecules the subsequent devices ought to be recycled are as follows HPLC method, Chromatography,
Ultraviolet-visible (UV-VIS) spectrophotometry, Infrared (IR) spectrometry and Mass spectrometry.
Related Pharma Societies | Pharma Associations
Society for Clinical Trials
, Association of Clinical Research, The Society of Clinical Research Associates, Clinical Research Society, American Association of Pharmaceutical Scientists, Association of British Pharmaceutical Industry
, Indian Society for Clinical Organization Research (ISCR), Pharmaceutical Information and Pharmacovigilance Association (PIPA), Pharmaceutical Society Of Hong Kong (PSNZ), Pharmaceutical Association of Mauritius(PAM),
International Society of Pharmacovigilance (ISOP),
Pharmaceutical Conferences 2019,
Drug Formulation Congress 2019,
Novel Drug Delivery Conferences, Pharmaceutical Drug Formulation, Drug Information Association, The Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT),
European Association for Clinical Pharmacology and Therapeutics (EACPT)
